Search Results - "Guskey, Michael"

Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive‐enhancing medications by Espay, Alberto J., Guskey, Michael T., Norton, James C., Coate, Bruce, Vizcarra, Joaquin A., Ballard, Clive, Factor, Stewart A., Friedman, Joseph H., Lang, Anthony E., Larsen, Niccole J., Andersson, Candace, Fredericks, Doral, Weintraub, Daniel

“…ABSTRACT Background: PD psychosis is often associated with cognitive impairment, including dementia, and involves dopaminergic, serotonergic, and cholinergic…”
Get full text

A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin by Guskey, Michael T., Tsuji, Brian T.

“…Resistance to antibiotics among gram‐positive bacteria, especially enterococci and staphylococci, has led to the need to develop new antibiotics. Vancomycin, a…”
Get full text

158 Open-label Study of Pimavanserin Patients with Comorbid Parkinson's Disease and Depression by Guskey, Michael T, Alva, Gustavo, Aldred, Jason L, Coate, Bruce, DeKarske, Daryl, Cantillon, Marc, Norton, James C

“…Depression occurs in ~50% of Parkinson's disease (PD) patients, increases in severity and duration as the disease progresses, and is associated with increased…”
Get full text

Pimavanserin for Treatment of Comorbid Depression in Patients With Parkinson’s Disease (4516) by Guskey, Michael, Alva, Gustavo, Aldred, Jason, Coate, Bruce, Abler, Victor, Cantillon, Marc, Norton, James, DeKarske, Daryl

“…Abstract only…”
Get full text

A POST HOC ANALYSIS OF STUDY ACP-103-019 EVALUATING THE IMPACT OF A REDUCTION IN PSYCHOSIS ON THE SEVERITY OF AGITATION AND AGGRESSION IN PATIENTS WITH ALZHEIMER'S DISEASE by Guskey, Michael, Norton, James, Coate, Bruce, Owen, Randy, Stankovic, Srdjan, Ballard, Clive

“…The objective of this post hoc analysis was to evaluate whether Alzheimer's disease (AD) patients with psychosis who experience an improvement in their…”
Get full text